|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,086 JPY | -1.18% |
|
+5.95% | -13.26% |
| 10/05 | Takara Bio Inc. Proposes Dividend for the Fiscal Year Ending March 31, 2024, Effective June 24, 2024 | CI |
| 18/03 | Takara Bio Inc.(TSE:4974) dropped from FTSE All-World Index | CI |
Takara Bio Inc. reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was JPY 78,142 million compared to JPY 67,699 million a year ago. Net income was JPY 16,012 million compared to JPY 19,849 million a year ago.
Basic earnings per share from continuing operations was JPY 132.97 compared to JPY 164.84 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -13.26% | 852M | |
| +33.63% | 50.85B | |
| -0.09% | 42.82B | |
| +49.62% | 42.03B | |
| -4.96% | 29.55B | |
| +11.18% | 26.11B | |
| -21.95% | 19.13B | |
| +8.61% | 13.05B | |
| +28.31% | 12.16B | |
| +24.73% | 12.08B |
TAKARA BIO INC. 
